Home › NDC Lookup › RxCUI directory › RxCUI 1494827

Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Medicated Pad [Plexion] — RxCUI 1494827

Name: Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Medicated Pad [Plexion] (RxCUI 1494827)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1494827 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1494827

Official nameSulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Medicated Pad [Plexion]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asPlexion (sulfacetamide sodium 9.8 % / sulfur 4.8 % ) Cleansing Cloth; Plexion 9.8 % / 4.8 % Medicated Pad

FDA products mapped1

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sulfacetamide Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's an antibiotic drop that targets bacterial infections on the surface of your eye. The most common reason it's prescribed is conjunctivitis — what most people call pink eye — ca...
What is this eye drop actually treating?
At the start of treatment, you'll use them quite frequently — typically every two to three hours. As your eye starts to get better, your doctor will usually have you space the dose...
How often do I need to put the drops in?

📖 Read our full Sulfacetamide Ophthalmic guide →

🕸️ Concept Web — How Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Medicated Pad [Plexion] RxCUI 1494827 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Sulfacetamide 10169 IN
- Sulfur 10223 IN
- Sulfacetamide / sulfur 690740 MIN
- Sulfacetamide sodium 82101 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Plexion 352897 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Sulfacetamide / sulfur Medicated Pad 797906 SCDF
- Sulfacetamide sodium / sulfur Medicated Pad 2648785 SCDFP
- Sulfacetamide / sulfur Medicated Pad or Tape 1162330 SCDG
- Sulfacetamide / sulfur Topical Product 1162333 SCDG
- Sulfacetamide sodium / sulfur Medicated Pad or Tape 2660430 SCDGP
- Sulfacetamide sodium / sulfur Topical Product 2662055 SCDGP
- Sulfacetamide / sulfur Medicated Pad [Plexion] 797908 SBDF
- Sulfacetamide sodium / sulfur Medicated Pad [Plexion] 2656244 SBDFP
- +5 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Medicated Pad 1494170 SCD
- Sulfacetamide sodium 98 MG/ML 1494167 SCDC
- Sulfur 48 MG/ML 1494168 SCDC
- Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML [Plexion] 1494823 SBDC

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Medicated Pad SCD · 1494170
Sulfacetamide sodium 98 MG/ML SCDC · 1494167
Sulfur 48 MG/ML SCDC · 1494168
Sulfacetamide / sulfur Medicated Pad SCDF · 797906
Sulfacetamide sodium / sulfur Medicated Pad SCDFP · 2648785
Sulfacetamide / sulfur Medicated Pad or Tape SCDG · 1162330
Sulfacetamide / sulfur Topical Product SCDG · 1162333
Sulfacetamide sodium / sulfur Medicated Pad or Tape SCDGP · 2660430
Sulfacetamide sodium / sulfur Topical Product SCDGP · 2662055

Brand-Name Concepts

Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML [Plexion] SBDC · 1494823
Sulfacetamide / sulfur Medicated Pad [Plexion] SBDF · 797908
Sulfacetamide sodium / sulfur Medicated Pad [Plexion] SBDFP · 2656244
Plexion Medicated Pad or Tape SBDG · 1181805
Plexion Topical Product SBDG · 1181807
Plexion BN · 352897

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1494827 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
57883-0404-10	10 PACKET in 1 CARTON (57883-404-10) / 4 g in 1 PACKET (578...	Plexion	Brava Pharmaceuticals, LLC	2005-09-01
57883-0404-60	60 PACKET in 1 CARTON (57883-404-60) / 4 g in 1 PACKET (578...	Plexion	Brava Pharmaceuticals, LLC	2005-09-01

Observed labelers: Brava Pharmaceuticals, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.